2,5-dimethyl-1H-imidazole-4-carboxylic acid, 95.0%, 1g

2-(5-Methyl-furan-2-yl)-benzaldehyde, 95.0%, 1g

Nazartinib, 50mg

Ethyl (3S,4R)-1-(tert-butyl)-4-(2,4-difluorophenyl)pyrrolidine-3-carboxylate, 95%, 250mg

Ethyl 2-cyano-3-(2-fluorophenyl)acrylate, 97+%, 1g

Chloromethyl-1,1,1,3,3,3-hexafluoroisopropyl ether, 99.0%, 5g

Buffer solution pH 11.00 ±0.05 (20 °C), ROTI®Calipure ready to use, 500 ml

4-(1h-1,3-Benzodiazol-2-ylsulfanyl)aniline, 97%, 250mg

tert-Butyl N-methyl-N-(pyrrolidin-3-yl)carbamate hydrochloride, 98+%, 500mg

Ethyl 3-aminoquinoline-2-carboxylate, 97%, 2.5g

N-Methylphenylalanine, 97.0%, 5g

5-Bromo-4-chloro-m-xylene, 95.0%, 1g

2-(2-(BENZYLOXY)ETHOXY)ETHYL 4-METHYLBENZENESULFONATE, 95.0%, 1g